hina In Vitro Diagnostics (IVD) Market Research Report Analysis 2018 – 2025

China in vitro diagnostics(IVD) market is anticipated to grow over US$ 11 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 – 2025.
The market is driven by number of factors such as rising incidences of chronic lifestyle diseases, public health awareness, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of private hospitals and independent testing laboratories.
“China In Vitro Diagnostics (IVD) Market Analysis 2012 – 2017 and Forecast 2018 – 2025: Clinical Chemistry, Immunoassay, Molecular Testing, SMBG, Point of Care Testing (POCT), Hematology, Coagulation, Microbiology, Genetic Testing, Infectious Diagnostics, Histology and Cytology” presents an in-depth assessment of the in vitro diagnostics(IVD) market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for in vitro diagnostics(IVD) in China. The research includes historic data from 2012 to 2017 and forecasts until 2025.
The report contains a granular analysis of the China in vitro diagnostics market segmentation by 11 applications and illustrative forecast to 2025. A comprehensive analysis has been done on market share of China in vitro diagnostics by application, end-user and company share by revenue.
The report also includes assessment of in vitro diagnostics regulation in China. Key trends in terms of partnerships and recent developments are analyzed with details. The report also explores detailed description of growth drivers, restraints, trends and opportunities of the China in vitro diagnostics market.
Market Segmentation by Application and Analysis (2012 – 2025)
•Clinical Chemistry
• Immunoassay
•Molecular Testing
• Self–Monitoring of Blood Glucose (SMBG)
•Point of Care Testing (POCT)
•Hematology
•Coagulation
•Microbiology
• Genetic Testing
• Infectious Diagnostics
• Histology and Cytology
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• Sysmex Corporation
• Mindray Medical International Limited
• Beckman Coulter Inc
• Shanghai Fosun Pharmaceutical Group
• Thermo Fisher Scientific Inc
• Hologic Inc
• Qiagen
• Cepheid
• Bio-Rad Laboratories Inc
• Da An Gene Co. Ltd
• Shanghai Kehua Bio–Engineering Co. Ltd.
The Latest Industry Data Included in this Report:
• China In Vitro Diagnostics Market Revenue & Forecast (2012 – 2025)
• China In Vitro Diagnostics Market Dynamics
• China In Vitro Diagnostics Market Segmentation by Application (2012 – 2025)
• China In Vitro Diagnostics Market Revenue Share by Application (2012 – 2025)
• China In Vitro Diagnostics Market, Company Share by Revenue, 2017
• China In Vitro Diagnostics Market Share by End-User (Hospitals, Homecare, Research Institutes, Independent laboratories),2017
• Assessment of In Vitro Diagnostics Regulation in China
• Major Partnership Deals in China In Vitro Diagnostics Market
• Recent Developments in China In Vitro Diagnostics Market
• Overview of Key Companies in China In Vitro Diagnostics Market

United States Non-Invasive Prenatal Testing Market 2018

United States Non-Invasive Prenatal Testing(NIPT) Market is likely to reach nearly USD 1 Billion by the year end of 2023.
Market growth can be attributed to factors such as rapid penetration of high and average risk NIPT test, high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT, shifting trend towards child bearing at advanced maternal age (35 years or older), launch of new and advanced NIPT products. With increased patient access to NIPT test, United States NIPT test market is anticipated to have a positive outlook in the coming years.
The research report titled “United States Non-Invasive Prenatal Testing(NIPT) Market Insights, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2023”examines the market, competitive landscape and trends of the United States NIPT Test Market. The study provides an in–depth analysis of the actual and potential NIPT test market.
The report provides a decisive view on the NIPT Test volume and market in United States. It also covers reimbursement pattern and offers a clear view of the regulatory landscape in the United States NIPT Test Market. Additionally, the report includes insights into the NIPT implementation in the high-income countries. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States NIPT Test Market.
The report concludes with the profiles of major players in the United States NIPT Test Market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolio, NIPT test analysis with volume and market revenue and latest development and trends of the NIPT Test Market.
Key Topics Covered in the Report
• United States Actual NIPT Test Volume & Market Revenue (2015 – 2023)
• United States Potential NIPT Test Volume & Market Revenue (2015 – 2023)
• United States Average Risk Actual NIPT Test Volume & Market Revenue (2015 – 2023)
• United States Average Risk Potential NIPT Test Volume & Market Revenue (2015 – 2023)
• United States High Risk Actual NIPT Test Volume & Market Revenue (2015 – 2023)
• United States High Risk Potential NIPT Test Volume & Market Revenue (2015 – 2023)
• United States NIPT Test Market – Reimbursement & Regulation System
• NIPT Test Implementation in High–Income Countries
• United States NIPT Test Market – Comparative Test Analysis
• United States NIPT Test Market – Major Deal Types
• Key Companies Analysis
• Key Drivers and Inhibitors of the United States NIPT Test Market
Key Companies Covered in the Report are as follows:
• Sequenom Laboratories (LabCorp)
• Ariosa Diagnostics (Roche)
• Illumina
• Natera
• Quest Diagnostics

Non-Invasive Prenatal Testing Market

The Potential Non-Invasive Prenatal Testing(NIPT) Market is expected to reach more than USD 4 Billion across the 15 major markets(15MM) by the year end of 2021.

More Information @ http://www.dpiresearch.com/page_info.php?P_ID=50

Long–term Growth Projection:

More than 2.5 Million tests will be conducted by the 11 major NIPT test by the year end of 2021.

Non-Invasive Prenatal Testing (NIPT) market size was valued at nearly USD 1 Billion in 2016 and market is expected to grow at the CAGR of XX% during 2017-2021.

Market growth can be attributed to factors such as high incidence rate of babies born with Down syndrome, no risk of miscarriage with NIPT and shifting trend towards child bearing at advanced maternal age (35 years or older). With increased patient access to NIPT test, the NIPT test market is anticipated to have a positive outlook in the coming years. High test cost, strict regulatory requirements and ethical hurdles is restraining the growth of NIPT test market.

NIPT Test Market: Test–wise Outlook

Natera Panorama test will lead the NIPT test market with the market share of more than 25% by the year end of 2021.MaterniT21 Plus and Bambini test have shown its potential to become 2nd and 3rd popular NIPT test. Harmony test is the fourth leading test in the NIPT test market. NIFTY and Verifi test hold the fifth and sixth highest share of the NIPT test market. Other emerging tests such as Prena, IONA, VisibiliT, Veracity and informaseq NIPT test which is likely to affect the market share during the forecast period.

 

NIPT Test Market: Country–wise Outlook:

United States is the most attractive market with market share of more than 50% in 2016. China will be the second largest market for NIPT test which is expected to grow at a CAGR of XX% by 2021. United Kingdom is expected to be third largest NIPT test market being followed by Germany by the end of the forecasted period.

This is the 3rd edition report on NIPT Test Market by DPI Research.The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, country wise actual and potential market, NIPT test analysis with volume and market revenue and competitive landscape. The report also covers market growth drivers, challenges, current and upcoming trends of the NIPT test market

 

GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SEGMENTATION

Global Non-Invasive Prenatal Testing (NIPT) Market – By Test Type

 

1.    MaterniT21 PLUS

2.    Harmony

3.    NIFTY

4.    Verifi

5.    Panorama

6.    PrenaTest

7.    BambniTest

8.    informaSeq

9.    VisibiliT

10.  Veracity

11.  IONA Test

 

Global Non-Invasive Prenatal Testing (NIPT) Market – By Country

 

1.    United States

2.    United Kingdom

3.    Germany

4.    Italy

5.    Spain

6.    France

7.    Switzerland

8.    Sweden

9.    Belgium

10.  Australia

11.  New Zealand

12.  Japan

13.  China

14.  India

15.  Brazil